Abstract: Synthesis of coordination compounds of zinc(II), copper(II), nickel(II), cobalt(II), and iron(II) with mixed piperaquine-acetaminophen and piperaquine-acetylsalicylic acid has been studied. The complexes were characterized via the following: solubility test, melting point determination, conductivity measurement, atomic absorption spectroscopy, UV-Visible spectrophotometry, FTIR spectroscopy and magnetic susceptibility. The complexes were proposed to have a stoichiometry ratio of 1:1:1 between each metal salt and the ligands with tetrahedral and octahedral geometry following the reaction pattern of MX.yH2O + L1L2/3 to give ML1L2/3X.yH2O. Biological activities of the synthesized complexes have been evaluated against Escherichia coli and Staphylococcus aureus.
INTRODUCTION
Malaria is one of the major devastating diseases affecting humans since the dawn of history.
Over half a billion people are infected with malaria parasite while more than a million die annually from its effect [1] . Children and mostly people with low-income economy are more vulnerable; averagely 3000 children die daily from malaria in Africa [2] . Malaria is caused by an infection of the body by single-cell plasmodia protozoa; though being a very simple organism, it has a complex life cycle with many forms [3] . Since the discovery of the naturally-occurring alkaloids, quinine is an effective therapeutic drug against malaria, numerous antimalarial drugs such as quinacrine, chloroquine, sulfadoxine, etc have been in circulation, until the parasites developed resistance against most of them. Currently, pyrimethamine, sulfonamide, artemisinin, and its derivatives, halofantrine, clindamycin, piperaquine, etc are mostly in use [4] . The parasites are developing resistance against most of the monotherapy antimalarial drugs, making them less effective; thus, the emergence of combination therapy in forms of Artemisinin Combination Therapies (ACTs) e. g. Coartem (R) , Artekin (R) etc. Fansidar (R) is another combination therapy containing sulfadoxine and pyrimethamine; which possess a better efficacy against the monotherapy-resistant malarial parasites than their respective single forms [5] . Piperaquine is a derivative of quinine, belonging to the 4-aminoquinoline groups. It was replaced for chloroquine in 1978 in China as a first line monotherapy for malaria and metric tons were dispensed for mass prophylaxis until resistant become too high [6] . Recently, piperaquine had become an object of renewed interest as a partner drug in ACTs. Dihydroartemisinin-piperaquine (Artekin) is one of the most common artemisinin combination for effective, short-course, and affordable malaria therapy with limited side effects and lower risks of recurrence of falciparum parasite [7] . Synriam (R) , containing 150 mg arterolane maleate and 750 mg piperaquine phosphate is an oral fixed-dose combination antimalarial for Plasmodium falciparum and Plasmodium vivax in children and adults [8] . These and many more justify the aim of this research effort; to develop an antimalarial-analgesic fixed combination therapy against the strains of monotherapy-resistant plasmodium parasites especially those associated with fever and severe pain symptoms. Thus, the synthesis of piperaquine-acetaminophen and piperaquineacetylsalicylic acid becomes a worth-taking approach of antimalarial research.
Materials
All chemicals used are of analytical and reagent grades, used as commercially obtained without further purification. Piperaquine phosphate (antimalarial ligand) was obtained from Zhuhai Runde Pharmaceutical Ltd., Guangzhou province, China, while acetaminophen and acetylsalicylic acid (analgesic ligands) were obtained from Rajrab Pharmeceutical Ltd., Ilorin. Transition metal salts and other solvents were obtained from Aldrich, BDH England.
EXPERIMENTAL

Synthesis of mixed piperaquine-acetaminophen metal complexes
The complexes were synthesized following some reported procedure with slight analytical modifications [5], [9] , [10] . An aqueous-ethanolic solution of each metal salt (0.01 mol of each)
was prepared in a round-bottomed flask. 5.355 g (0.01 mol) of piperaquine phosphate was mixed with 1.512 g (0.01 mol) of acetaminophen in a beaker. The mole ratio of the mixture of piperaquine phosphate, metal salt and acetaminophen was 1:1:1. The mixed ligands were dissolved in 20 mL of 5% lactic acid due to poor solubility of piperaquine in water even when fully ionized [19] and added to each solution of the corresponding metal salt dissolved previously in 10 mL of ethanol in a round-bottomed flask fitted with a condenser. The pH of the mixture was maintained by the addition of 10% methanolic ammonical solution. The mixture was refluxed at 70˚C for 4 hours and kept thereafter in a refrigerator for 30 minutes for the metal chelate to crystallize. The crystals were then filtered and washed with dilute lactic acid and then distilled water to remove unreacted ligands and metals. The complexes were then dried in a desiccator for 3 days. The same procedure was applied for all metal salts.
Synthesis of mixed piperaquine-acetylsalicylic acid metal complexes
The procedure as reported above [5] , [9] , [10] was followed with some slight modifications such as change in analgesic ligands and the reflux time.
Determination of some properties of the complexes
Physical observations of the colors of the synthesized complexes were made and compared with those of the free ligands and the metal salts. The percentage yields were calculated and approximated to the nearest whole number. The melting points and conductivities were measured using Gallenkamp melting point apparatus and WTW conductimeter bridge, respectively and the values were recorded to a single whole number without range. Purity of the complexes was confirmed as a single spot on a thin layer chromatography (TLC) plate. Magnetic susceptibilities were deduced from the magnetic moment obtained on Sherwood Scientific
Magnetic Susceptibility Balance. Infrared spectra of the synthesized complexes and the free ligands were recorded in KBr pellets using a Shimadzu FTIR-8400s (IR solution model) in the range of 4000 -500 cm -1
. As a UV-Visible spectrometer, Beckman Coulter DU-730 was used to run the electronic transition of the complexes and the free ligands. Atomic Absorption Spectroscopy (AAS) analysis was used to determine the metal content of the complexes (which confirms evidence of coordination) was carried out using the Alpha 4 AAS PM 8251 single pen recorder.
Antimicrobial Screening
Antimicrobial activities of the free ligands and the complexes were deduced from their inhibitory potentials against Escherichia coli and Staphylococcus aureus on the basis of zones formed around their wells [5], [9] . Table 1 
Results
DISCUSSIONS
The complexes (Table 2) show different colors due to the presence of transition metal charge transfer to the ligands transition compared to the free ligands [11] , [12] . The percentage yield of the complexes varied due to different factors such as the variation in electronic configuration of the metal ion in d-orbital, size of the ion, nature of the electron donation agent (donating atom on the ligand), functional groups of the ligands as Lewis bases and the reaction conditions [12] . The highest percentage yield was observed in Zn(PQ)(PC)SO4 while the lowest was found in Zn(PQ)(AS)SO4. The synthesized complexes were photo-and thermo-stable crystals with varied melting points due to the octahedral and tetrahedral geometry (Figures 1-3 ) of the transition metal complexes. The melting points of free piperaquine (PQ) ligand are higher than those of the complexes [9] . The percentage metal content as found experimentally is in good agreement with the calculated values as the data in Table 2 reveal. Molar conductivities of the metal complexes in water show non-electrolytic behavior of the free ligands and the complexes in the solvent.
The results of solubility tests ( The results of the magnetic moment (Table 4) solution [18] . The formation of single spots on each TLC chromatography plate confirmed the purity of the complexes.
The proposed reaction pathways and chemical formulas as given in Table 4 above are derived from the cumulative characterization results. Table 5 
